Log In
Print
BCIQ
Print
Print this Print this
 

Ultresa, pancrelipase

  Manage Alerts
Collapse Summary General Information
Company Actavis plc
DescriptionDelayed-release pancrelipase formulation
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard IndicationPancreatic insufficiency
Indication DetailsTreat exocrine pancreatic insufficiency due to cystic fibrosis (CF)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today